Homocysteic Acid in Blood Can Detect Mild Cognitive Impairment: A Preliminary Study

BACKGROUND: In the treatment of Alzheimer’s disease (AD), it is thought to be most effective to intervene at the earliest and mildest stages. For diagnosis at the earliest and mildest stages, it is desirable to use a biomarker that can be detected by a minimally invasive, cost-effective technique. R...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasegawa, Tohru, Kosoku, Yoshinori, Sano, Yuka, Yoshida, Hiroshi, Kudoh, Chiaki, Tabira, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592685/
https://www.ncbi.nlm.nih.gov/pubmed/32741817
http://dx.doi.org/10.3233/JAD-200234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592685/
https://www.ncbi.nlm.nih.gov/pubmed/32741817
http://dx.doi.org/10.3233/JAD-200234

Ejemplares similares